Peter Kolonoski

1.4k total citations
27 papers, 1.1k citations indexed

About

Peter Kolonoski is a scholar working on Epidemiology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Peter Kolonoski has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 23 papers in Infectious Diseases and 9 papers in Organic Chemistry. Recurrent topics in Peter Kolonoski's work include Mycobacterium research and diagnosis (25 papers), Tuberculosis Research and Epidemiology (21 papers) and Quinazolinone synthesis and applications (9 papers). Peter Kolonoski is often cited by papers focused on Mycobacterium research and diagnosis (25 papers), Tuberculosis Research and Epidemiology (21 papers) and Quinazolinone synthesis and applications (9 papers). Peter Kolonoski collaborates with scholars based in United States, South Korea and Poland. Peter Kolonoski's co-authors include Luiz E. Bermudez, Lawrence S. Young, Clark B. Inderlied, Mary Petrofsky, Martin Wu, Lowell S. Young, Joseph R. Goodman, Félix J. Sangari, Robert Bolan and Lory D. Wiviott and has published in prestigious journals such as The Lancet, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

Peter Kolonoski

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Kolonoski United States	19	831	722	230	186	167	27	1.1k
Mary Petrofsky United States	24	1.0k 1.2×	859 1.2×	136 0.6×	244 1.3×	294 1.8×	37	1.4k
Malin Ridell Sweden	22	1.1k 1.3×	964 1.3×	187 0.8×	393 2.1×	181 1.1×	82	1.6k
A Y Tsang United States	17	847 1.0×	626 0.9×	225 1.0×	220 1.2×	61 0.4×	18	981
Matt D. Johansen Australia	19	799 1.0×	637 0.9×	184 0.8×	280 1.5×	171 1.0×	44	1.2k
Andrés Obregón‐Henao United States	21	543 0.7×	763 1.1×	83 0.4×	299 1.6×	285 1.7×	45	1.2k
Venkata M. Reddy United States	19	493 0.6×	610 0.8×	135 0.6×	398 2.1×	54 0.3×	25	949
Philip Draper United Kingdom	11	747 0.9×	783 1.1×	113 0.5×	461 2.5×	68 0.4×	12	1.1k
Pamela J. Lindholm-Levy United States	20	1.0k 1.2×	1.1k 1.5×	199 0.9×	405 2.2×	31 0.2×	23	1.3k
Л. Н. Черноусова Russia	18	593 0.7×	661 0.9×	124 0.5×	298 1.6×	53 0.3×	89	1.0k
Benjamin G. Schroeder United States	10	774 0.9×	974 1.3×	133 0.6×	680 3.7×	129 0.8×	11	1.6k

Countries citing papers authored by Peter Kolonoski

Since Specialization

Citations

This map shows the geographic impact of Peter Kolonoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kolonoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kolonoski more than expected).

Fields of papers citing papers by Peter Kolonoski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kolonoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kolonoski. The network helps show where Peter Kolonoski may publish in the future.

Co-authorship network of co-authors of Peter Kolonoski

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kolonoski. A scholar is included among the top collaborators of Peter Kolonoski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kolonoski. Peter Kolonoski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosser, Joelle I., Ralph Tayyar, Peter Kolonoski, et al.. (2021). Case-control study evaluating risk factors for SARS-CoV-2 outbreak amongst healthcare personnel at a tertiary care center. American Journal of Infection Control. 49(12). 1457–1463. 8 indexed citations

Kolonoski, Peter, Kim Stanley, & Karen M. Anderson. (2012). An Interdisciplinary Approach Toward Reducing the Incidence of Catheter-associated Urinary Tract Infections in a Post-acute Facility. American Journal of Infection Control. 40(5). e54–e55. 1 indexed citations

Bermudez, Luiz E., Peter Kolonoski, Robert J. Bildfell, et al.. (2008). The Efficacy of Clarithromycin and the Bicyclolide EDP‐420 againstMycobacterium aviumin a Mouse Model of Pulmonary Infection. The Journal of Infectious Diseases. 197(11). 1506–1510. 10 indexed citations

Bermudez, Luiz E., Gyulnar Baimukanova, Peter Kolonoski, et al.. (2007). EDP-420, a Bicyclolide (Bridged Bicyclic Macrolide), Is Active against Mycobacterium avium. Antimicrobial Agents and Chemotherapy. 51(5). 1666–1670. 9 indexed citations

Bermudez, Luiz E., Peter Kolonoski, Mary Petrofsky, et al.. (2004). SRI-286, a Thiosemicarbazole, in Combination with Mefloquine and Moxifloxacin for Treatment of Murine Mycobacterium avium Complex Disease. Antimicrobial Agents and Chemotherapy. 48(9). 3556–3558. 35 indexed citations

Bermudez, Luiz E., Peter Kolonoski, Mary Petrofsky, et al.. (2003). Mefloquine, Moxifloxacin, and Ethambutol Are a Triple‐Drug Alternative to Macrolide‐Containing Regimens for Treatment ofMycobacterium aviumDisease. The Journal of Infectious Diseases. 187(12). 1977–1980. 38 indexed citations

Bermudez, Luiz E., et al.. (2003). Thiosemicarbazole (Thiacetazone-Like) Compound with Activity against Mycobacterium avium in Mice. Antimicrobial Agents and Chemotherapy. 47(8). 2685–2687. 35 indexed citations

Bermudez, Luiz E., et al.. (2001). Telithromycin Is Active against Mycobacterium avium in Mice despite Lacking Significant Activity in Standard In Vitro and Macrophage Assays and Is Associated with Low Frequency of Resistance during Treatment. Antimicrobial Agents and Chemotherapy. 45(8). 2210–2214. 18 indexed citations

Sangari, Félix J., Joseph R. Goodman, Mary Petrofsky, Peter Kolonoski, & Luiz E. Bermudez. (2001). Mycobacterium avium Invades the Intestinal Mucosa Primarily by Interacting with Enterocytes. Infection and Immunity. 69(3). 1515–1520. 54 indexed citations

10.

Bermudez, Luiz E., Clark B. Inderlied, Peter Kolonoski, et al.. (2001). Activity of Moxifloxacin by Itself and in Combination with Ethambutol, Rifabutin, and Azithromycin In Vitro and In Vivo against Mycobacterium avium. Antimicrobial Agents and Chemotherapy. 45(1). 217–222. 42 indexed citations

11.

Bermudez, Luiz E., et al.. (1999). Mefloquine Is Active In Vitro and In Vivo againstMycobacterium aviumComplex. Antimicrobial Agents and Chemotherapy. 43(8). 1870–1874. 68 indexed citations

12.

Bermudez, Luiz E., Clark B. Inderlied, Peter Kolonoski, Martin Wu, & Lowell S. Young. (1998). Activity of HMR3004 against Mycobacterium avium complex in vitro, in human macrophages and in beige mice. Clinical Microbiology and Infection. 4(6). 325–331. 3 indexed citations

13.

Bermudez, Luiz E., Peter Kolonoski, & Lawrence S. Young. (1996). Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice. Antimicrobial Agents and Chemotherapy. 40(4). 1033–1035. 9 indexed citations

14.

Bermudez, Luiz E., et al.. (1996). Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice. Antimicrobial Agents and Chemotherapy. 40(3). 546–551. 27 indexed citations

15.

Bermudez, Luiz E., José Eduardo Martinelli, Mary Petrofsky, Peter Kolonoski, & Lawrence S. Young. (1994). Recombinant Granulocyte-Macrophage Colony-Stimulating Factor Enhances the Effects of Antibiotics against Mycobacterium avium Complex Infection in the Beige Mouse Model. The Journal of Infectious Diseases. 169(3). 575–580. 50 indexed citations

16.

Bermudez, Luiz E., Mary Petrofsky, Peter Kolonoski, & Lawrence S. Young. (1992). An Animal Model of Mycobacterium avium Complex Disseminated Infection after Colonization of the Intestinal Tract. The Journal of Infectious Diseases. 165(1). 75–79. 95 indexed citations

17.

Young, Lawrence S., et al.. (1991). Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. The Lancet. 338(8775). 1107–1109. 157 indexed citations

18.

Bermudez, Luiz E., Peter Kolonoski, & Lowell S. Young. (1990). Natural Killer Cell Activity and Macrophage-Dependent Inhibition of Growth or Killing of Mycobacterium avium Complex in a Mouse Model. Journal of Leukocyte Biology. 47(2). 135–141. 39 indexed citations

19.

Inderlied, Clark B., Peter Kolonoski, Mingfang Wu, & Lawrence S. Young. (1989). In Vitro and In Vivo Activity of Azithromycin (CP 62,993) Against the Mycobacterium avium Complex. The Journal of Infectious Diseases. 159(5). 994–997. 63 indexed citations

20.

Bermudez, Luiz E., Paul Stevens, Peter Kolonoski, Martin Wu, & Lawrence S. Young. (1989). Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor.. The Journal of Immunology. 143(9). 2996–3000. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact